Literature DB >> 18374903

Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.

Xinjie Liu1, Qizheng Han, Ruopeng Sun, Zhaoxia Li.   

Abstract

Accumulating evidences have demonstrated that matrix metalloproteinases (MMPs) contribute to the pathophysiology of bacterial meningitis. MMPs facilitate leukocyte extravasation and brain edema by degradation of extracellular matrix components. Dexamethasone as adjunctive therapy to antibiotics has shown to have beneficial effects on pathophysiological changes and neurological outcome in children with meningitis and in animal models. However, the role of dexamethasone in the pathophysiology of pneumococcal meningitis is still unknown. The effects of antibiotics on MMPs in bacterial meningitis have not been evaluated so far. We have therefore intended to investigate the induction and expression of MMPs with special emphasis on the regulation of MMPs by dexamethasone and antibiotics in therapy of pneumococcal meningitis. In the present study, the expression of MMP-9 and MMP-2 mRNA in the brain of rats and the activity of MMP-9 and MMP-2 in the CSF of rats have been determined during the course of experimental bacterial meningitis and after treatment with an antibiotic plus dexamethasone. In the brain tissue of rats with Streptococcus pneumococcal meningitis, MMP-9 mRNA was obviously up-regulated after inoculation for 24 h (p<0.01) and then declined but was still greater than that in the brains of control rats after inoculation for 4 days (p<0.05) while the expression of MMP-2 remained at basal level. The expression of MMP-9 in the brains of rats inoculated with Streptococcus pneumoniae and treated by antibiotic was dose-dependent, up-regulated (p<0.01) but down-regulated after treatment with an antibiotic plus dexamethasone (p<0.01). However, the expression of MMP-9 mRNA did not change in the rats inoculated with sterile saline and treated with an antibiotic. The zymographic activity of MMP-9 and MMP-2 showed similar changes. The results indicated that the expression of MMP-9 mRNA and its activity might be increased after antibiotic treatment and inhibited after treatment with antibiotics plus dexamethasone; dexamethasone might have a beneficial effect on bacterial meningitis via down-regulation of the expression of MMP-9.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374903     DOI: 10.1016/j.brainres.2008.01.106

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

Review 1.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

2.  The Balance of Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Autoimmune Inner Ear Disease Patients.

Authors:  Logan Eisner; Andrea Vambutas; Shresh Pathak
Journal:  J Interferon Cytokine Res       Date:  2017-07-11       Impact factor: 2.607

3.  Expression of matrix metalloproteinases 1, 3, and 9 in differing extents of tendon retraction in the torn rotator cuff.

Authors:  Stefan Lakemeier; Juliane Braun; Turgay Efe; Christian Foelsch; Eleni Archontidou-Aprin; Susanne Fuchs-Winkelmann; Juergen R J Paletta; Markus D Schofer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-01-11       Impact factor: 4.342

4.  Excess maternal glucocorticoids in response to in utero undernutrition inhibit offspring angiogenesis.

Authors:  Omid Khorram; Reza Ghazi; Tsai-Der Chuang; Guang Han; Joshua Naghi; Youping Ni; William J Pearce
Journal:  Reprod Sci       Date:  2013-10-23       Impact factor: 3.060

5.  Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.

Authors:  Xiaomeng Ma; Ying Jiang; Aimin Wu; Xiaohong Chen; Rongbiao Pi; Mei Liu; Yingying Liu
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

6.  NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae.

Authors:  Xinjie Liu; Vinita S Chauhan; Amy B Young; Ian Marriott
Journal:  Glia       Date:  2010-05       Impact factor: 7.452

7.  A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.

Authors:  Susan M Blaney; Michael Tagen; Arzu Onar-Thomas; Stacey L Berg; Sri Gururangan; Kathleen Scorsone; Jack Su; Stewart Goldman; Mark W Kieran; Larry Kun; Jim Boyett; Clinton Stewart
Journal:  Pediatr Blood Cancer       Date:  2012-09-21       Impact factor: 3.167

Review 8.  Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms.

Authors:  Roger Murayi; Prashant Chittiboina
Journal:  Childs Nerv Syst       Date:  2016-09-09       Impact factor: 1.475

9.  Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis.

Authors:  Justin A Green; Chau T H Tran; Jeremy J Farrar; Mai T H Nguyen; Phu H Nguyen; Sinh X Dinh; Nghia D T Ho; Chuong V Ly; Hien T Tran; Jon S Friedland; Guy E Thwaites
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

Review 10.  Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics.

Authors:  Björn Pasternak; Per Aspenberg
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.